Revision as of 18:05, 29 July 2010 editPotatoBot (talk | contribs)Bots51,239 editsm Stub sorting and placement of stub template(s)← Previous edit | Revision as of 14:22, 18 April 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (Next edit → | ||
Line 1: | Line 1: | ||
{{Unreferenced stub|auto=yes|date=December 2009}} | {{Unreferenced stub|auto=yes|date=December 2009}} | ||
{{Drugbox | {{Drugbox | ||
| verifiedrevid = 376126506 | |||
| IUPAC_name = | | IUPAC_name = | ||
| image = Tyloxapol.png | | image = Tyloxapol.png |
Revision as of 14:22, 18 April 2011
This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Tyloxapol" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message) |
Clinical data | |
---|---|
ATC code | |
Identifiers | |
CAS Number | |
PubChem CID | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.209.660 |
Chemical and physical data | |
Formula | (C15H21O(C2H4O)m)n |
Molar mass | variable |
(verify) |
Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type. It is used as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions, administered by inhalation through a nebulizer or with a stream of oxygen. With intraperitoneal injection, tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins.
This drug article relating to the respiratory system is a stub. You can help Misplaced Pages by expanding it. |